Print

Stemline Therapeutics, Inc. (STML) to Present at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013  
2/27/2013 1:29:16 PM

NEW YORK, Feb. 27, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk, announced today that Ivan Bergstein, M.D., Chief Executive Officer, will present at the Cowen and Company 33rd Annual Health Care Conference on Monday, March 4, 2013 at 4:50PM ET. The conference will take place at the Boston Marriott Copley Place in Boston, Massachusetts.
//-->